What Baseline Tests Are Needed for Antisynthetase Syndrome?
At a Glance
After an antisynthetase syndrome diagnosis, baseline testing usually assesses the lungs, heart, muscles, antibodies, and overall treatment safety. High-resolution CT, lung function tests, blood work, and heart testing help detect organ involvement and guide monitoring.
When your care team suspects or has just diagnosed you with antisynthetase syndrome, establishing a clear picture of how the condition is affecting your body is critical. Antisynthetase syndrome can involve multiple organs—often before you feel symptoms in all of them. Therefore, doctors use a combination of tests to confirm the diagnosis, look for organ involvement, and create a monitoring baseline.
These initial evaluations help your team track your condition over time and ensure treatments are done safely. The specific tests ordered will be individualized based on your symptoms, examination, and treatment plan.
High-Resolution CT (HRCT) of the Lungs
Interstitial lung disease (ILD), which causes inflammation and scarring in the lungs, is extremely common in antisynthetase syndrome [1]. Importantly, lung involvement can be present even if you do not have a cough or shortness of breath [2][3][4]. A high-resolution CT (HRCT) scan is the preferred imaging test for creating detailed pictures of your lungs to detect early signs of ILD and determine its pattern [1][5]. Because CT scans involve radiation, your doctor will carefully consider when to repeat this test.
Pulmonary Function Tests (PFTs)
Pulmonary function tests measure how well your lungs are working. Your baseline PFTs should include spirometry (measuring how much air you can breathe in and out) and a measurement of carbon monoxide diffusing capacity (DLCO) [5][6]. DLCO uses a very small, safe amount of test gas to assess how well oxygen passes from your lungs into your blood.
PFTs and HRCT scans are complementary. You might have early signs of ILD on a scan but still have normal PFTs, or a low DLCO could be influenced by other factors like anemia or pulmonary hypertension. A complete lung assessment might also include full lung volumes, measuring your oxygen saturation at rest and with activity, or a six-minute walk test.
Echocardiogram
An echocardiogram is an ultrasound of the heart. For patients with antisynthetase syndrome, a baseline echocardiogram helps estimate the likelihood of pulmonary hypertension (high blood pressure in the arteries of the lungs) [7][8]. In one registry, pulmonary hypertension affected about 9% of patients, making it a crucial complication to watch for [7]. It is important to know that an echocardiogram does not definitively diagnose pulmonary hypertension; if the results are abnormal or if your DLCO is disproportionately low, your doctor may refer you for a specialized procedure called a right-heart catheterization. Because antisynthetase syndrome can affect the heart in other ways, your doctor might also order an ECG or check cardiac biomarkers [9].
Muscle Tests and Enzymes
Antisynthetase syndrome can cause inflammation in the muscles (myositis). Your doctor will likely order blood tests to check the levels of muscle enzymes, including creatine kinase (CK) and aldolase [10][11]. Other markers like LDH or AST/ALT may also be checked, though AST and ALT can also indicate liver issues [12].
Elevated levels can indicate active muscle damage. However, normal or only slightly elevated CK levels do not completely rule out active muscle inflammation [13][14]. Your doctor will interpret these blood tests alongside a physical exam checking your muscle strength, your daily physical function, and sometimes imaging like a muscle MRI or an electromyogram (EMG) if your blood tests and symptoms disagree [13][14].
Extended Myositis Antibody Panel
A specialized blood test called an extended myositis antibody panel identifies the specific autoantibodies associated with the syndrome. The anti-Jo-1 antibody is the most common, but panels often check for other antisynthetase antibodies (such as PL-7, PL-12, EJ, OJ, and KS) [15].
The panel may also test for myositis-associated antibodies, like anti-Ro52. While anti-Ro52 has been associated with lung disease in studies, it is a possible risk-assessment clue and not a guarantee of how your individual disease will progress [16][1][17]. Be aware that commercial antibody panels can sometimes miss certain antibodies; a negative panel does not completely rule out the syndrome if your clinical picture strongly suggests it [18][19].
General Health and Treatment Safety Testing
Before starting systemic immunosuppressants, your doctor will need to run general baseline and safety tests. These commonly include:
- Complete blood count (CBC)
- Kidney and liver function tests
- Inflammatory markers
- Screening for infections like Hepatitis B/C, Tuberculosis, and HIV
- Pregnancy testing, if applicable
Safety Warning: Do not wait for routine follow-up tests if you experience emergencies. Seek prompt medical advice for new or rapidly worsening breathlessness, low oxygen, chest pain, fainting, choking, trouble swallowing, or rapidly worsening muscle weakness.
Common questions in this guide
Why do I need several baseline tests after an antisynthetase syndrome diagnosis?
Which lung tests are usually done for antisynthetase syndrome?
Can my lung function be normal if antisynthetase syndrome affects my lungs?
What blood tests check for muscle involvement and antisynthetase antibodies?
What heart tests are used at baseline?
What safety tests are needed before immunosuppressive treatment?
When should I contact my care team urgently?
One line in your results can change your plan.
If blood test results and symptoms disagree, your doctor may order a muscle MRI or EMG. We check your results against the latest research to help you prepare for what’s next.
Related questions
Show more
Get notified when new evidence is published on Antisynthetase syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (19)
- 1
Analysis of the clinical features of antisynthetase syndrome: a retrospective cohort study in China.
Wang R, Zhao Y, Qi F, et al.
Clinical rheumatology 2023; (42(3)):703-709 doi:10.1007/s10067-022-06404-8.
PMID: 36308573 - 2
Interstitial lung disease in patients with antisynthetase syndrome: a retrospective case series study.
Baratella E, Marrocchio C, Cifaldi R, et al.
Japanese journal of radiology 2021; (39(1)):40-46 doi:10.1007/s11604-020-01030-3.
PMID: 32876818 - 3
Antisynthetase syndrome: An under-recognized cause of interstitial lung disease.
Maturu VN, Lakshman A, Bal A, et al.
Lung India : official organ of Indian Chest Society 2016; (33(1)):20-6 doi:10.4103/0970-2113.173055.
PMID: 26933302 - 4
A Multidisciplinary Evaluation Helps Identify the Antisynthetase Syndrome in Patients Presenting as Idiopathic Interstitial Pneumonia.
Chartrand S, Swigris JJ, Peykova L, et al.
The Journal of rheumatology 2016; (43(5)):887-92 doi:10.3899/jrheum.150966.
PMID: 26932342 - 5
Management and outcomes of interstitial lung disease associated with anti-synthetase syndrome: a systematic literature review.
Kouranloo K, Dey M, Elwell H, et al.
Rheumatology (Oxford, England) 2025; (64(1)):45-55 doi:10.1093/rheumatology/keae403.
PMID: 39083028 - 6
Pulmonary Involvement in the Antisynthetase Syndrome: A Comparative Cross-sectional Study.
Andersson H, Aaløkken TM, Günther A, et al.
The Journal of rheumatology 2016; (43(6)):1107-13 doi:10.3899/jrheum.151067.
PMID: 27036381 - 7
Pulmonary hypertension in anti-synthetase syndrome: prevalence, comparative risk across autoimmune diseases and impact on survival.
Bae SS, Rivero Gallegos D, Bozan F, et al.
Rheumatology (Oxford, England) 2026; (65(10)) doi:10.1093/rheumatology/keag543.
PMID: 42809241 - 8
Antisynthetase syndrome and pulmonary hypertension: report of two cases and review of the literature.
García-Fernández A, Quezada-Loaiza CA, de la Puente-Bujidos C
Modern rheumatology case reports 2021; (5(1)):152-155 doi:10.1080/24725625.2020.1794521.
PMID: 32697139 - 9
Echocardiographic characteristics of patients with antisynthetase syndrome.
Bryan JL, Matar R, Raviprasad A, et al.
Pulmonary circulation 2022; (12(2)):e12084 doi:10.1002/pul2.12084.
PMID: 35514779 - 10
Polymyositis-Like Myopathy With Anti-PL-12 Antibody Positivity and Coexisting Antiphospholipid Syndrome: Diagnostic and Management Challenges in the Absence of Systemic Features.
Parga AD, Raheem I
Cureus 2025; (17(1)):e78002 doi:10.7759/cureus.78002.
PMID: 40007921 - 11
Antisynthetase syndrome and interstitial lung disease: A case report.
Dahal K, Chaudhary A, Rawal L, et al.
Annals of medicine and surgery (2012) 2022; (82()):104571 doi:10.1016/j.amsu.2022.104571.
PMID: 36268301 - 12
Evaluating the value of superoxide dismutase in anti-synthetase syndrome associated with interstitial lung disease.
Luo L, Huang W, Ren F, et al.
Clinical rheumatology 2026; (45(6)):3555-3563 doi:10.1007/s10067-026-07973-8.
PMID: 41952032 - 13
Comparative analyses of muscle MRI and muscular function in anti-synthetase syndrome patients and matched controls: a cross-sectional study.
Andersson H, Kirkhus E, Garen T, et al.
Arthritis research & therapy 2017; (19(1)):17 doi:10.1186/s13075-017-1219-y.
PMID: 28122635 - 14
Dropped head syndrome leading to the diagnosis of antisynthetase syndrome: a motor neuron mimicker.
Duman İlki C, Pek G, Özaydın Aksun Z, Şener HÖ
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2026; (47(1)):109.
PMID: 41493482 - 15
Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
Srivastava P, Dwivedi S, Misra R
Rheumatology international 2016; (36(7)):935-43 doi:10.1007/s00296-016-3494-3.
PMID: 27193471 - 16
Clinical heterogeneity and prognostic factors of anti-synthetase syndrome: a multi-centred retrospective cohort study.
Tang HS, Tang IYK, Ho RTC, et al.
Rheumatology (Oxford, England) 2025; (64(1)):212-220 doi:10.1093/rheumatology/kead671.
PMID: 38096583 - 17
Clinical Characteristics of Anti-Synthetase Syndrome and Variables Associated with Interstitial Lung Disease and Mortality: A Retrospective Cohort Study.
Sodsri T, Petnak T, Ngamjanyaporn P
Journal of clinical medicine 2023; (12(21)) doi:10.3390/jcm12216849.
PMID: 37959314 - 18
TEST performance of a myositis panel in a clinical immunology laboratory in New South Wales, Australia.
Tan TC, Wienholt L, Adelstein S
International journal of rheumatic diseases 2016; (19(10)):996-1001 doi:10.1111/1756-185X.12792.
PMID: 26621603 - 19
Skeletal Muscle Involvement in Antisynthetase Syndrome.
Noguchi E, Uruha A, Suzuki S, et al.
JAMA neurology 2017; (74(8)):992-999 doi:10.1001/jamaneurol.2017.0934.
PMID: 28586844
This page explains common baseline tests after an antisynthetase syndrome diagnosis for informational purposes only and does not constitute medical advice. Your care team should decide which tests you need and interpret your results.